Rituximab decreases without preference all subclasses of IgG anti-BP180 autoantibodies in refractory bullous pemphigoid (BP)

被引：10
|
作者：
Ronaghy, Arash [1 ]
Streilein, Robert D. [1 ]
Hall, Russell P., III [1 ]
机构：
[1] Duke Univ, Med Ctr, Dept Dermatol, Durham, NC 27710 USA
来源：
JOURNAL OF DERMATOLOGICAL SCIENCE | 2014年 / 74卷 / 01期
关键词：
Bullous pemphigoid; Auto-antibodies: IgG subclass; Rituximab; BP180; ECTODOMAIN;
D O I：
10.1016/j.jdermsci.2013.11.014
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：93 / 94
页数：2
相关论文
共 43 条
  • [21] Checkpoint Inhibition May Trigger the Rare Variant of Anti-LAD-1 IgG-Positive, Anti-BP180 NC16A IgG-Negative Bullous Pemphigoid
    Sadik, Christian D.
    Langan, Ewan A.
    Graetz, Victoria
    Zillikens, Detlet
    Terheyden, Patrick
    FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [22] Correlation of autoantibodies against BP180/BP230 in response to topical corticosteroids in patients with bullous pemphigoid
    Schneiderbauer, Roland
    Martinache, Stefanie
    Engstner, Monika
    Enk, Alexander H.
    Hadaschik, Eva N.
    DERMATOLOGIC THERAPY, 2016, 29 (06) : 419 - 423
  • [23] Evaluation of ELISA BP180 and BP230 Autoantibodies in Blister Fluid and Serum in the Diagnosis of Bullous Pemphigoid
    Nagarajan, Harish
    Mahadevan, Krishnaswamy
    Rai, Reena
    Boppe, Appalaraju
    INDIAN JOURNAL OF DERMATOLOGY, 2023, 68 (01)
  • [24] IgG autoantibody reactivity against bullous pemphigoid (BP) 180 and BP230 in elderly patients with pruritic dermatoses
    Feliciani, C.
    Caldarola, G.
    Kneisel, A.
    Podstawa, E.
    Pfuetze, M.
    Pfuetzner, W.
    Hertl, M.
    BRITISH JOURNAL OF DERMATOLOGY, 2009, 161 (02) : 306 - 312
  • [25] Expression of Serum Anti-BP180/230 Antibodies in Bullous Pemphigoid Patients Combined with Nervous System Diseases and Relevant Factor Analysis
    Liu, Guili
    Li, Bingnan
    Zhao, Zishen
    Qin, Lanying
    Zhao, Yuanying
    Fang, Shuo
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2024, 34 (02): : 141 - 145
  • [26] Bullous pemphigoid with IgG autoantibodies to BP180 C-terminal domain and desmocollin 3 associated with transverse colon cancer
    Hiroko Yamashita
    Shin-ichi Ansai
    Takashi Ueno
    Shin-ichi Osada
    Seiji Kawana
    Hiroshi Koga
    Norito Ishii
    Takashi Hashimoto
    European Journal of Dermatology, 2015, 25 : 515 - 516
  • [27] Evaluation of the Role of BIOCHIP Mosaic Based Indirect Immunofluorescence and ELISA BP 180 and BP 230 Autoantibodies in the Diagnosis of Bullous Pemphigoid Patients
    Nithya, V. P. S.
    Rai, Reena
    Boppe, Appalaraju
    Chaithra, V
    INDIAN DERMATOLOGY ONLINE JOURNAL, 2022, 13 (06) : 754 - 756
  • [28] Anti-BP230 IgE autoantibodies in bullous pemphigoid intraindividually correlate with disease activity
    Emtenani, Shirin
    Linnemann, Beke E.
    Recke, Andreas
    von Georg, Anabelle
    Goletz, Stephanie
    Schmidt, Enno
    van Beek, Nina
    JOURNAL OF DERMATOLOGICAL SCIENCE, 2024, 114 (02) : 64 - 70
  • [29] IgE anti-BP180 NC16A autoantibody in both serum and blister fluid samples does not correlate with disease activity of bullous pemphigoid
    Sun, Chao
    Qian, Hua
    Liang, Guirong
    Xiang, Ruiyu
    Zhao, Chenjing
    Li, Zhiliang
    Li, Suo
    Jing, Ke
    Wang, Yuan
    Zhang, Hanmei
    Li, Xiaoguang
    Feng, Suying
    EUROPEAN JOURNAL OF DERMATOLOGY, 2023, 33 (06) : 595 - 603
  • [30] Autoantibodies to the extracellular and intracellular domain of bullous pemphigoid 180, the putative key autoantigen in bullous pemphigoid, belong predominantly to the TgG1 and IgG4 subclasses
    Laffitte, E
    Skaria, M
    Jaunin, F
    Tamm, K
    Saurat, JH
    Favre, B
    Borradori, L
    BRITISH JOURNAL OF DERMATOLOGY, 2001, 144 (04) : 760 - 768
12345